|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.48 USD | -0.55% |
|
+5.69% | +21.07% |
| Market Cap | 9.66B 8.5B 7.91B 7.26B 13.64B 927B 13.82B 94.01B 36.72B 458B 36.28B 35.5B 1,582B | P/E 2026 * |
12.2x | P/E 2027 * | 9.38x |
|---|---|---|---|---|---|
| Enterprise Value | 10.99B 9.66B 8.99B 8.26B 15.5B 1,054B 15.71B 107B 41.74B 520B 41.24B 40.36B 1,798B | EV / Sales 2026 * |
6.22x | EV / Sales 2027 * | 4.92x |
| Free-Float |
98.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Halozyme Therapeutics, Inc.
| 1 day | -0.55% | ||
| 1 week | +5.69% | ||
| Current month | +4.10% | ||
| 1 month | +8.70% | ||
| 3 months | +26.35% | ||
| 6 months | +16.04% | ||
| Current year | +21.07% |
| 1 week | 76.82 |  | 83.5 |
| 1 month | 73.89 | | 83.5 |
| Current year | 61.32 | | 83.5 |
| 1 year | 57.68 | | 83.5 |
| 3 years | 32.83 | | 83.5 |
| 5 years | 29.85 | | 83.5 |
| 10 years | 8.18 | | 83.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 63 | 2014-01-05 |
David Ramsay
DFI | Director of Finance/CFO | 61 | 2013-04-30 |
| Director of Finance/CFO | - | 2026-06-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 59 | 2013-03-27 |
Helen Torley
BRD | Director/Board Member | 63 | 2014-01-05 |
| Chairman | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/8/26 | Fiscal year | Chief Executive Officer | 5,769 | 0.0049% | ||
| 7/1/26 | Free | Executive/Senior Manager | 56,055 | 0.0473% | ||
| 7/1/26 | Free | Chief Financial Officer | 168,986 | 0.1425% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.55% | +5.69% | +39.90% | +87.27% | 9.66B | |
| -0.24% | +5.11% | +54.36% | +24.21% | 323B | |
| +1.87% | +5.04% | +25.89% | -11.68% | 70.11B | |
| -0.08% | +0.11% | +3.36% | -1.19% | 8.51B | |
| +1.61% | +6.64% | -20.18% | -2.50% | 4.37B | |
| -3.87% | +4.05% | -41.18% | +10.04% | 3.66B | |
| +3.53% | +4.14% | -2.33% | +15.23% | 3.75B | |
| +1.69% | -0.93% | +39.90% | +55.92% | 2.73B | |
| +3.60% | -2.63% | -4.72% | -8.34% | 2.11B | |
| +1.63% | -0.45% | -14.93% | +27.83% | 1.87B | |
| Average | +0.73% | +1.65% | +8.01% | +19.68% | 42.97B | |
| Weighted average by Cap. | -0.15% | +3.11% | +45.63% | +18.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.77B 1.55B 1.45B 1.33B 2.49B 170B 2.53B 17.19B 6.72B 83.7B 6.64B 6.49B 289B | 2B 1.76B 1.64B 1.51B 2.83B 192B 2.87B 19.5B 7.62B 94.92B 7.52B 7.36B 328B |
| Net income | 812M 714M 665M 610M 1.15B 77.88B 1.16B 7.9B 3.09B 38.45B 3.05B 2.98B 133B | 1.03B 909M 846M 777M 1.46B 99.18B 1.48B 10.06B 3.93B 48.97B 3.88B 3.8B 169B |
| Net Debt | 1.32B 1.16B 1.08B 994M 1.87B 127B 1.89B 12.86B 5.02B 62.62B 4.96B 4.86B 216B | 205M 180M 168M 154M 289M 19.65B 293M 1.99B 778M 9.7B 769M 752M 33.53B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-27 | US$81.48 | -0.55% | 1,435,892 |
| 26-07-24 | US$81.93 | +1.35% | 1,661,209 |
| 26-07-23 | US$80.84 | +3.88% | 1,751,413 |
| 26-07-22 | US$77.82 | -0.99% | 1,399,919 |
| 26-07-21 | US$78.60 | +1.96% | 1,273,027 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HALO Stock
Select your edition
All financial news and data tailored to specific country editions
